Tuberculosis-Related Deaths within a Well-Functioning DOTS Control Program
Open Access
- 1 November 2002
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 8 (11) , 1327-1333
- https://doi.org/10.3201/eid0811.020021
Abstract
To describe the molecular epidemiology of tuberculosis (TB)-related deaths in a well-managed program in a low-HIV area, we analyzed data from a cohort of 454 pulmonary TB patients recruited between March 1995 and October 2000 in southern Mexico. Patients who were sputum acid-fast bacillus smear positive underwent clinical and mycobacteriologic evaluation (isolation, identification, drug-susceptibility testing, and IS6110-based genotyping and spoligotyping) and received treatment from the local directly observed treatment strategy (DOTS) program. After an average of 2.3 years of follow-up, death was higher for clustered cases (28.6 vs. 7%, p=0.01). Cox analysis revealed that TB-related mortality hazard ratios included treatment default (8.9), multidrug resistance (5.7), recently transmitted TB (4.1), weight loss (3.9), and having less than 6 years of formal education (2). In this community, TB is associated with high mortality rates.Keywords
This publication has 36 references indexed in Scilit:
- Patients with tuberculosis in Bolivia: why do they die?Revista Panamericana de Salud Pública, 2000
- Standard Short-Course Chemotherapy for Drug-Resistant TuberculosisJAMA, 2000
- Clinical Consequences and Transmissibility of Drug-Resistant Tuberculosis in Southern MexicoArchives of internal medicine (1960), 2000
- Who dies from what? Determining cause of death in South Africa's rural north‐eastTropical Medicine & International Health, 1999
- Noncompliance With Directly Observed Therapy for TuberculosisChest, 1997
- Deaths from active tuberculosis: Can we rely on notification and mortality figures?Tubercle and Lung Disease, 1996
- A Computer-Assisted Molecular Epidemiologic Approach to Confronting the Reemergence of TuberculosisThe Lancet Healthy Longevity, 1996
- Pulmonary Tuberculosis in HIV-Infected Patients in Zaire — A Controlled Trial of Treatment for Either 6 or 12 MonthsNew England Journal of Medicine, 1995
- The mortality and pathology of HIV infection in a West African cityAIDS, 1993
- Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programmeTubercle and Lung Disease, 1993